These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 28954785)

  • 21. Genomic profiling of a metastatic anaplastic melanocytic neuroectodermal tumor arising from a mature thymic teratoma as part of a mediastinal germ cell tumor.
    Mayeur S; Lhermitte B; Gantzer J; Molitor A; Stemmelen T; Meyer S; Kolmer A; Kurtz JE; Bahram S; Carapito R
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37160315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of platinum-based chemotherapy and pembrolizumab to treat squamous cell carcinoma arising in a mature teratoma of the ovary in a pre-menopausal woman with negative response: A case report.
    Martel RA; Marsh L; Lai T; Rodriguez-Triana VM; Moatamed NA; Cohen J
    Gynecol Oncol Rep; 2023 Jun; 47():101192. PubMed ID: 37131341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma.
    Tamura R; Nakaoka H; Yachida N; Ueda H; Ishiguro T; Motoyama T; Inoue I; Enomoto T; Yoshihara K
    Cancer Sci; 2023 May; 114(5):2145-2157. PubMed ID: 36762791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nivolumab for malignant transformation of ovarian mature cystic teratoma.
    Yoshimura K; Yamanoi K; Kanai M; Okunomiya A; Sagae Y; Sunada M; Taki M; Ukita M; Chigusa Y; Horie A; Yamaguchi K; Hamanishi J; Minamiguchi S; Yamamoto N; Muto M; Mandai M
    Gynecol Oncol Rep; 2022 Dec; 44():101115. PubMed ID: 36560959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing.
    Hocking LJ; Andrews C; Armstrong C; Ansari M; Baty D; Berg J; Bradley T; Clark C; Diamond A; Doherty J; Lampe A; McGowan R; Moore DJ; O'Sullivan D; Purvis A; Santoyo-Lopez J; Westwood P; Abbott M; Williams N; ; Aitman TJ; Miedzybrodzka Z
    Eur J Hum Genet; 2023 Feb; 31(2):231-238. PubMed ID: 36474026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DUSP5 and PHLDA1 mutations in mature cystic teratomas of the ovary identified on whole-exome sequencing may explain teratoma characteristics.
    Wang WC; Lai YC
    Hum Genomics; 2022 Oct; 16(1):50. PubMed ID: 36289533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of the cancer driver genes constructs a seven-gene signature for prediction of survival and tumor immunity in hepatocellular carcinoma.
    Zou J; Qin W
    Front Genet; 2022; 13():937948. PubMed ID: 36017503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 30-Year Experience With 22 Cases of Malignant Transformation Arising From Ovarian Mature Cystic Teratoma: A Rare Disease.
    Li Y; Qin M; Shan Y; Wu HW; Liu XD; Yin J; Gu Y; Wang W; Wang YX; Chen JY; Ma L; Jin Y; Pan LY
    Front Oncol; 2022; 12():842703. PubMed ID: 35615156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.
    Cheng Z; Mirza H; Ennis DP; Smith P; Morrill Gavarró L; Sokota C; Giannone G; Goranova T; Bradley T; Piskorz A; Lockley M; ; Kaur B; Singh N; Tookman LA; Krell J; McDermott J; Macintyre G; Markowetz F; Brenton JD; McNeish IA
    Clin Cancer Res; 2022 Jul; 28(13):2911-2922. PubMed ID: 35398881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case Report: Management of Recurrent Ovarian Squamous Cell Carcinoma With PD-1 Inhibitor.
    Song XC; Wang YX; Yu M; Cao DY; Yang JX
    Front Oncol; 2022; 12():789228. PubMed ID: 35356229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal evidence for the development of neuroblastoma with extensive copy-neutral loss of heterozygosity arising in a mature teratoma.
    Ono R; Ueno H; Yoshida K; Takahashi S; Yoshihara H; Nozaki T; Suzuki K; Nakazawa A; Saiki R; Seki M; Takita J; Ogawa S; Manabe A; Hasegawa D
    Cancer Sci; 2021 Jul; 112(7):2921-2927. PubMed ID: 33934450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Profiling of Malignant Melanoma Arising from an Ovarian Mature Cystic Teratoma: A Case Report.
    Nakamura K; Aimono E; Takamatsu R; Tanishima S; Tohyama T; Sasano K; Sakuma H; Nishihara H
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous Cell Carcinoma Arising From a Mature Cystic Teratoma of the Ovary: A Case Report.
    Rave Ramirez A; Arencibia-Sánchez O; Andújar Sánchez M; Martin Martinez A; Laseca-Modrego M
    Cureus; 2021 Jan; 13(1):e12846. PubMed ID: 33633884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue Sections.
    Macintyre G; Piskorz AM; Berman A; Ross E; Morse DB; Yuan K; Ennis D; Pike JA; Goranova T; McNeish IA; Brenton JD; Markowetz F
    JCO Clin Cancer Inform; 2021 Feb; 5():176-186. PubMed ID: 33570999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NRG1 fusions in breast cancer.
    Howarth KD; Mirza T; Cooke SL; Chin SF; Pole JC; Turro E; Eldridge MD; Garcia RM; Rueda OM; Boursnell C; Abraham JE; Caldas C; Edwards PAW
    Breast Cancer Res; 2021 Jan; 23(1):3. PubMed ID: 33413557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database.
    Zhang C; Ma T
    J Ovarian Res; 2020 Jul; 13(1):75. PubMed ID: 32611433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of ovarian squamous cell carcinoma with MET gene copy number variation: a case report and review of literature.
    Dong X; Yuan L; Yao L
    J Ovarian Res; 2020 May; 13(1):62. PubMed ID: 32475345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary.
    Tamura R; Yoshihara K; Nakaoka H; Yachida N; Yamaguchi M; Suda K; Ishiguro T; Nishino K; Ichikawa H; Homma K; Kikuchi A; Ueda Y; Takei Y; Fujiwara H; Motoyama T; Okuda S; Wakai T; Inoue I; Enomoto T
    Oncogene; 2020 Apr; 39(17):3541-3554. PubMed ID: 32115573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic mutations in intracranial arteriovenous malformations.
    Goss JA; Huang AY; Smith E; Konczyk DJ; Smits PJ; Sudduth CL; Stapleton C; Patel A; Alexandrescu S; Warman ML; Greene AK
    PLoS One; 2019; 14(12):e0226852. PubMed ID: 31891627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review.
    Li C; Zhang Q; Zhang S; Dong R; Sun C; Qiu C; Zhang Z; Yang X; Kong B
    BMC Cancer; 2019 Mar; 19(1):217. PubMed ID: 30866852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.